PartnershipUpdated on 20 November 2025
Detox.AI - accelerating safer drug discovery
Student at Hochschule für Technik und Wirtschaft Berlin
Berlin, Germany
About
Detox.AI is an innovative platform focused on accelerating drug discovery by providing fast, reliable, and explainable toxicity predictions. Leveraging a combination of machine learning models, molecular graphs, and public toxicology data, Detox.AI helps researchers identify potential safety risks early in the development process. The platform bridges chemistry and biology, offering insights into molecular mechanisms while maintaining computational efficiency. Our goal is to empower pharma and biotech teams with actionable information, reduce experimental costs, and speed up the path to safer therapeutics. With a strong foundation from hackathon success and a dedicated team including Ganesh Thorbole, Kira Kravets, and Antonio Sanmateu, Detox.AI combines expertise in ML, life sciences, and graph-based modeling to deliver a unique and scalable solution for the drug discovery ecosystem.
Looking for
- Joint development
Similar opportunities
Investment
Truth-grounded AI for biotech/pharma/healthcare
- Start-Up
- Technology
Angelina Lesnikova
CEO at sci2sci
Berlin, Germany
Expertise
Global Development Strategy & Regulatory Affairs
Michael Firgens
CEO/ Founder, MF BIOTECH at MF BIOTECH
Berlin, Germany
Expertise
Tailored Biomarker Solutions for your Clinical Programs
- DISEASE AREA | Cancer
- MEDICINE | Diagnostics
- MEDICINE | Cell Therapy
- MEDICINE | Early Detection
- MEDICINE | RNA-based Therapy
- MEDICINE | Therapy Monitoring
- MEDICINE | Biomarker Discovery
- DISEASE AREA | Metabolic Diseases
- DISEASE AREA | Infectious Diseases
- TECHNOLOGY | (Single-cell) multi-omics
- DISEASE AREA | Inflammation / Autoimmune Diseases
Andreas Hüser
CEO at CheckImmune GmbH
Berlin, Germany